Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease

This publication has 20 references indexed in Scilit:

• Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada
  Vaccine, 2003
• Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
  BMJ, 2003
• Effectiveness of meningococcal C conjugate vaccine in teenagers in England
  The Lancet, 2003
• Instituting a routine varicella vaccination program in Canada: an economic evaluation
  The Pediatric Infectious Disease Journal, 2002
• Development of vaccines against meningococcal disease
  The Lancet, 2002
• Ability of 3 Different Meningococcal C Conjugate Vaccines to Induce Immunologic Memory after a Single Dose in UK Toddlers
  The Journal of Infectious Diseases, 2001
• Mucosal Immune Responses to Meningococcal Group C Conjugate and Group A and C Polysaccharide Vaccines in Adolescents
  Infection and Immunity, 2000
• The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996
  The Journal of Infectious Diseases, 1999
• Meningococcal Serogroup C Conjugate Vaccine Is Immunogenic in Infancy and Primes for Memory
  The Journal of Infectious Diseases, 1999
• Serogroup C meningococcal outbreaks in the United States. An emerging threat
  JAMA, 1995